semaglutide hepatic impairment child pugh 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Child-Pugh classification for degree of

Nat Neurosci 10:15441553 Leonardi A, Abbruzzese G, Arata L et al (1984) Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis

The peak-to-trough variation in drug levels with daily oral dosing versus weekly injectable dosing may also affect overall efficacy, particularly for outcomes like appetite suppression that benefit from steady drug levels

The decision of the courts could have a major impact on the outcome of Rybelsus lawsuits

Semaglutide remains one of the most effective GLP-1 medications for weight loss, but many patients experience a slowdown in results after several months of treatment

That figure is wrong by more than a factor of three